Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells

M. Kučírek, AJ. Bagherpoor, J. Jaroš, A. Hampl, M. Štros,

. 2019 ; 33 (12) : 14307-14324. [pub] 20191026

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023386

Grantová podpora
NV16-31501A MZ0 CEP - Centrální evidence projektů

High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-3β/β-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA+ transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.-Kučírek, M., Bagherpoor, A. J., Jaroš, J., Hampl, A., Štros, M. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023386
003      
CZ-PrNML
005      
20201214125913.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1096/fj.201901465RRR $2 doi
035    __
$a (PubMed)31661640
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kučírek, Martin $u Laboratory of Analysis of Chromosomal Proteins, Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
245    10
$a HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells / $c M. Kučírek, AJ. Bagherpoor, J. Jaroš, A. Hampl, M. Štros,
520    9_
$a High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-3β/β-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA+ transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.-Kučírek, M., Bagherpoor, A. J., Jaroš, J., Hampl, A., Štros, M. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells.
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a protein HMGB1 $x genetika $7 D024243
650    _2
$a protein HMGB2 $x genetika $x fyziologie $7 D024261
650    _2
$a lidské embryonální kmenové buňky $x cytologie $x enzymologie $7 D000066449
650    _2
$a lidé $7 D006801
650    _2
$a kmenové buňky $x cytologie $x enzymologie $7 D013234
650    _2
$a telomerasa $x metabolismus $7 D019098
650    _2
$a genetická transkripce $7 D014158
650    _2
$a transfekce $7 D014162
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bagherpoor, Alireza J $u Laboratory of Analysis of Chromosomal Proteins, Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Jaroš, Josef $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cell and Tissue Regeneration, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Hampl, Aleš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cell and Tissue Regeneration, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Štros, Michal $u Laboratory of Analysis of Chromosomal Proteins, Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
773    0_
$w MED00001782 $t FASEB journal : official publication of the Federation of American Societies for Experimental Biology $x 1530-6860 $g Roč. 33, č. 12 (2019), s. 14307-14324
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31661640 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125912 $b ABA008
999    __
$a ok $b bmc $g 1595705 $s 1114062
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 33 $c 12 $d 14307-14324 $e 20191026 $i 1530-6860 $m The FASEB journal $n FASEB J $x MED00001782
GRA    __
$a NV16-31501A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...